Kiniksa Pharmaceuticals International Cash Flow Statement (2017-2026) | KNSA

Cash Flow Statement Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-41.56M-30.54M-44.08M-25.21M-19.98M224.09M-90.63M-12.27M14.97M-13.86M-83.03M-17.70M-3.91M-12.69M-1.21M8.54M17.83M18.43M14.20M22.59M
Depreciation and Depletion (Quarter)
0.42M0.37M0.38M0.36M0.35M0.18M0.29M0.29M0.29M0.29M0.24M0.15M0.12M0.09M0.09M0.04M0.01M0.03M0.12M0.14M
Share-based Compensation (Quarter)
5.72M6.20M6.13M6.03M6.68M6.04M6.37M6.12M6.47M6.79M7.77M7.21M7.36M7.83M8.30M7.75M8.88M10.14M10.23M10.06M
Deferred Taxes (Quarter)
0.35M1.08M-19.44M10.29M-25.71M4.37M10.57M-3.64M-3.16M2.99M2.64M4.23M3.14M4.52M
Gains from Sales and Divestitures (Quarter)
0.16M0.17M0.23M0.25M0.12M0.27M0.47M0.06M0.30M0.60M0.05M0.34M0.70M0.77M0.02M
Gains from Investment Securities (Quarter)
0.65M0.60M-1.16M-2.75M1.01M0.60M2.89M-0.17M10.96M1.24M-11.50M0.38M0.49M11.63M3.57M-0.01M0.42M0.94M1.14M0.77M
Non-cash Items (Quarter)
4.57M4.53M14.95M5.15M5.25M5.53M32.63M5.98M6.53M7.01M54.65M7.49M7.91M7.61M62.33M7.76M7.23M6.65M213.29M6.14M
Cash from Operations (Quarter)
-38.78M-28.51M-18.88M-36.85M-7.82M62.05M-11.58M-4.27M-3.74M16.99M4.33M3.99M5.17M-2.24M18.77M22.32M28.09M33.68M53.89M50.20M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.19M-0.01M-0.05M-0.16M-0.08M0.12M0.20M1.06M1.15M-1.44M0.30M-0.30M0.19M0.49M-0.82M-0.26M0.84M-0.60M0.93M-1.30M
Depreciation & Amortization (CF) (Quarter)
0.72M0.66M0.67M0.66M0.65M0.49M0.60M0.60M0.60M0.60M0.54M0.47M0.43M0.40M0.40M0.34M0.36M0.38M0.47M0.47M
Change in Working Capital
Change in Receivables (Quarter)
0.67M0.69M25.45M-21.63M3.35M1.50M-5.24M17.23M-21.61M18.23M-5.27M4.46M4.44M16.84M-1.66M-8.15M19.83M-36.15M7.63M
Change in Inventory (Quarter)
-0.78M-1.93M9.55M6.69M-5.29M6.98M1.83M0.53M1.62M5.54M-3.84M7.58M-6.18M-2.32M-4.29M26.11M-6.79M13.50M18.25M
Change in Account Payables (Quarter)
3.58M-2.54M0.25M1.51M-0.86M-1.05M6.43M-6.51M-0.74M0.36M7.23M-2.66M1.73M0.91M-6.28M0.06M6.93M-2.73M-4.12M22.27M
Change in Accured Expenses (Quarter)
1.67M-2.46M10.04M4.08M-5.97M1.97M-3.79M-10.65M14.69M7.61M5.29M3.29M18.66M10.80M10.99M-3.60M13.10M8.37M19.63M-5.05M
Other Working Capital Changes (Quarter)
0.33M-2.04M-0.85M0.00M-0.01M1.56M0.02M6.66M-4.73M-4.48M2.57M0.03M-0.48M16.96M3.04M-0.85M13.05M0.51M9.78M-0.99M
Investing Activities
Capital Expenditures (Quarter)
0.06M0.05M0.25M0.02M-0.03M0.02M0.03M0.02M0.06M0.10M-0.02M0.07M0.03M0.30M0.60M-0.85M0.11M
Sales of Property, Plant and Equipment (Quarter)
-0.01M0.01M
Change in Intangibles (Quarter)
Change in Acquisitions & Divestments (Quarter)
109.15M47.90M10.00M7.50M63.80M36.40M20.10M15.00M73.70M40.83M45.98M61.88M42.44M48.13M87.48M44.03M30.61M84.08M40.78M145.66M
Cash from Investing Activities (Quarter)
85.99M47.85M-50.04M-22.72M38.27M19.04M-42.66M-37.92M35.53M-12.28M-14.89M25.52M-46.80M-6.35M65.29M-51.54M-3.88M-62.76M-70.81M-31.92M
Financing Activities
Other financing activities (Quarter)
Cash from Financing Activities (Quarter)
0.89M2.68M1.21M0.42M0.54M0.36M1.19M0.09M0.16M0.55M0.69M3.61M-0.18M6.69M2.14M2.77M10.70M11.90M7.66M6.07M
Additional items
Change in Cash (Quarter)
48.10M22.02M-67.71M-59.15M30.98M81.45M-53.05M-42.10M31.95M5.26M-9.87M33.12M-41.81M-1.90M86.20M-26.45M34.91M-17.18M-9.26M24.36M
Free Cash Flow (Quarter)
-38.84M-28.56M-19.14M-36.85M-7.82M62.03M-11.54M-4.29M-3.78M16.97M4.27M3.88M5.19M-2.24M18.70M22.29M27.79M33.08M54.75M50.09M
Net Cash Flow (Quarter)
48.10M22.02M-67.71M-59.15M30.98M81.45M-53.05M-42.10M31.95M5.26M-9.87M33.12M-41.81M-1.90M86.20M-26.45M34.91M-17.18M-9.26M24.36M